Mode
Text Size
Log in / Sign up

Reduced Shannon index indicates lower alpha-diversity in the gut microbiota of patients with primary biliary cholangitisGut Microbiota Differences Linked to Primary Biliary Cholangitis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that reduced alpha-diversity in the gut microbiota is associated with primary biliary cholangitis.

This meta-analysis evaluated the impact of gut microbiota on patients with primary biliary cholangitis (PBC) compared to healthy controls. The analysis included 1,057 participants, consisting of 607 patients with PBC and 450 controls. The study focused on alpha-diversity indices, beta diversity, and taxonomic alterations as primary and secondary outcomes.

The meta-analysis found that the Shannon index was significantly lower in patients with PBC compared to controls (SMD = -0.72; 95% CI: -1.22 to -0.22). These results indicate a measurable reduction in alpha-diversity within the gut microbiota of those affected by the condition.

The authors noted limitations including small sample sizes in individual studies and methodological inconsistency across the included data. While these findings suggest that gut microbiota dysbiosis may contribute to pathogenesis and progression, the evidence is currently observational. Clinical application is limited by the lack of reported follow-up data and the need for further consistent research.

How this fits prior evidence

This meta-analysis addresses a gap in understanding the role of the microbiome in primary biliary cholangitis. While prior coverage has established that hepatic steatosis is common in autoimmune liver diseases but not specifically associated with worse outcomes in primary biliary cholangitis, this study provides evidence regarding gut microbiota diversity. The finding of lower Shannon index values (SMD = -0.72) suggests a specific microbial signature in PBC patients.

Researchers looked at the gut bacteria of over 1,000 people to see how it relates to primary biliary cholangitis. This condition affects the bile ducts in the liver. The study compared 607 patients with the condition against 450 healthy people.

The results showed that patients with primary biliary cholangitis had lower diversity in their gut bacteria, specifically measured by the Shannon index. While this shows a clear link between gut health and the condition, it is important to note that these findings are based on an observational analysis of existing data.

Because individual studies within the review were small and used different methods, the results should be viewed as preliminary. The study confirms a link between gut bacteria and the disease, but it does not prove that changing the gut bacteria will treat or cure the condition. Patients should talk to their doctors about how these findings might relate to their specific health needs.

What this means for you:
Patients with primary biliary cholangitis show lower gut bacterial diversity compared to healthy individuals.

Common questions

What did the study find about gut bacteria and primary biliary cholangitis?

The analysis of 1,057 participants showed that patients with primary biliary cholangitis had significantly lower gut bacterial diversity compared to healthy controls. Specifically, the Shannon index was notably lower in those with the condition. This suggests a link between the types of bacteria in the gut and the progression of the disease.

Is this finding enough to change how the disease is treated?

The study shows a clear association between gut microbiota and primary biliary cholangitis, but it does not provide evidence for a specific treatment. Because the data comes from an observational meta-analysis with some inconsistencies, you should consult your doctor before making any changes to your current medical plan.

How many people were included in this study?

The analysis included a total of 1,057 participants. This group consisted of 607 patients diagnosed with primary biliary cholangitis and 450 healthy individuals used as a comparison group to measure differences in gut bacterial diversity.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundPrimary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease. Increasing evidence suggests that gut microbiota dysbiosis may contribute to its pathogenesis and progression. However, existing studies are limited by small sample sizes, methodological inconsistency, and the lack of quantitative synthesis, resulting in insufficient consolidated evidence.ObjectiveThis systematic review and meta-analysis aimed to evaluate alterations in the gut microbiota of patients with PBC.MethodsPubMed, Web of Science, Embase, and the Cochrane Library were systematically searched from inception to January 23, 2026. Outcomes included alpha-diversity indices, beta diversity, and taxonomic alterations. Meta-analyses were performed using standardized mean differences (SMDs) with 95% confidence intervals (CIs). Sensitivity analysis, subgroup analysis, and meta-regression were conducted to explore potential sources of heterogeneity.ResultsOf 1,326 records screened, 10 studies involving 1,057 participants (607 patients with PBC and 450 controls) were included, and all studies had Newcastle–Ottawa Scale scores of at least 7. Compared with controls, patients with PBC had a significantly lower Shannon index (SMD = −0.72, 95% CI: −1.22 to −0.22, p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.